SCHEMBL17909976

SCHEMBL17909976

CNC[C@@H](C)[C@@H](O)[C@H](NC)C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
KISS1R Q969F8 4/20 0.34
KDM4E B2RXH2 4/20 0.33
TP53 P04637 1/20 0.33
HSD17B10 Q99714 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
SLC6A2 P23975 1/20 0.32
CYP1A2 P05177 1/20 0.32
ADRB2 P07550 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32
THPO P40225 1/20 0.32
BLM P54132 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HIF1A Q16665 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18630069 0.85 ALDH1A1 (0.38) ALDH1A1KISS1RKDM4ETP53HSD17B10
SCHEMBL2232837 0.82 ALDH1A1 (0.48) ALDH1A1L3MBTL1
SCHEMBL6207891 0.82 ALDH1A1 (0.48) ALDH1A1L3MBTL1
SCHEMBL8028251 0.82 ALDH1A1 (0.48) ALDH1A1L3MBTL1
SCHEMBL17909993 0.81 ALDH1A1 (0.35) ALDH1A1KISS1RTP53SMN1; SMN2
SCHEMBL6207226 0.78 ALDH1A1 (0.34) ALDH1A1TP53L3MBTL1
SCHEMBL10521929 0.78 ALDH1A1 (0.34) ALDH1A1TP53L3MBTL1
SCHEMBL8028244 0.78 ALDH1A1 (0.34) ALDH1A1TP53L3MBTL1
SCHEMBL8028253 0.78 ALDH1A1 (0.34) ALDH1A1TP53L3MBTL1
SCHEMBL8028249 0.78 ALDH1A1 (0.34) ALDH1A1TP53L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180094031-A1 CYCLOSPORIN DERIVATIVES WHEREIN THE MEBMT SIDECHAIN HAS BEEN CYCLIZED ALLERGAN, INC. 2018-04-05 US disclosed
US-9914755-B2 Cyclosporin derivatives wherein the MeBmt sidechain has been cyclized ALLERGAN, INC. (US) 2018-03-13 US disclosed
US-20160200767-A1 CYCLOSPORIN DERIVATIVES WHEREIN THE MEBMT SIDECHAIN HAS BEEN CYCLIZED ALLERGAN, INC. 2016-07-14 US disclosed
WO-2016112321-A1 CYCLOSPORIN DERIVATIVES WHEREIN THE MEBMT SIDECHAIN HAS BEEN CYCLIZED ALLERGAN, INC. (US) 2016-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180094031-A1 CYCLOSPORIN DERIVATIVES WHEREIN THE MEBMT SIDECHAIN HAS BEEN CYCLIZED CHP1, PPIB, FKBP1B ALDH1A1 3455/4885KISS1R 4750/4885KDM4E 4209/4885
US-20160200767-A1 CYCLOSPORIN DERIVATIVES WHEREIN THE MEBMT SIDECHAIN HAS BEEN CYCLIZED CHP1, PPIB, FKBP1B ALDH1A1 3455/4885KISS1R 4750/4885KDM4E 4209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.